Please Note:
This profile was automatically generated using 24 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 24 references found on the Internet. This information has not been verified. Learn more...
View all 24 references Web References
-
1. Treatment has demonstrated improvement in physical function and kept joint damage from progressing
www.eurekalert.org/pub_release - [Cached]Published on: 11/13/2005 Last Visited: 11/15/2005
Contact: Christine Cassiano, Amgen 805-447-4587
...
Christine Cassiano (media) -
2. Amgen - Media - Press Release
www-ext.amgen.com/media/media_ - [Cached]Published on: 8/2/2005 Last Visited: 11/29/2006
Christine Cassiano, 805-447-4587 (Media) -
3. Accelerator gets $11.8M to speed startup funding - 2004-11-22 - Puget Sound Business Journal (Seattle)
seattle.bizjournals.com/seattl - [Cached]Published on: 11/22/2004 Last Visited: 11/23/2004
But the typical investment in a company is likely to be $1 million to $3 million per round, with Amgen's goal of not owning more than 15 percent of a company, said Amgen spokeswoman Christine Cassiano.
Amgen strategy
Amgen Ventures allows parent Amgen to build a relationship with early-stage companies to help push for scientific innovations, said Cassiano. These startups may not be far enough along with their research for Amgen's licensing division to ink a deal. But the company thinks by starting a $100 million venture capital fund, it could lead to agreements down the road. "We definitely think it may pave the way for future collaboration," Cassiano said.
Cassiano said the venture fund is not designed to give Amgen the inside track on cornering any company's biotech research.

